CIEL 113059 Tranquilizers Causing Adverse Effect in Therapeutic Use Non-standardCIEL 114041 Liver Preparations and Antianemic Agents Causing Adverse Effect in Therapeutic Use Non-standardCIEL 117629 Drug-Induced Hematologic Reaction Non-standardCIEL 117669 Agent affecting blood constituents causing adverse effect in therapeutic use Non-standardCIEL 121760 Drugs and medicinal substances causing adverse effect in therapeutic use Non-standardCIEL 121764 Adverse drug effect Non-standardCIEL 123503 Uric acid metabolism drugs causing adverse effect in therapeutic use Non-standardCIEL 138431 Hormones and Synthetic Substitutes Causing Adverse Effect in Therapeutic Use Non-standardCIEL 141751 Adverse effect of gastrointestinal drug Non-standardCIEL 141752 Drug groups primarily affecting cardiovascular system adverse reaction Non-standardCIEL 141753 Drugs Primarily Affecting the Autonomic Nervous System Causing Adverse Effect in Therapeutic Use Non-standardCIEL 149268 Primarily systemic agents causing adverse effects in therapeutic use Non-standardCIEL 149273 Adverse reaction to parasympatholytic and spasmolytic Non-standardCIEL 149303 Agents primarily acting on the smooth and skeletal muscles and respiratory system causing adverse effect in therapeutic use Non-standardCIEL 149318 Adverse reaction to anti-common cold drugs Non-standardCIEL 149326 Adverse effect, due to correct medicinal substance properly administered Non-standardCIEL 151061 Antidotes and chelating agents, causing adverse effect in therapeutic use Non-standardCIEL 155081 Analgesic, antipyretic and anti-inflammatory drug, causing adverse effect in therapeutic use Non-standardCIEL 157515 Liver preparations and antianemic agents causing adverse effect Non-standardCIEL 157826 Mucolytic agent adverse reaction Non-standardCIEL 160644 Reaction (to an allergen)(text) Non-standardCIEL 160646 Reaction (to an allergen) Non-standardCIM10 T88.7 Unspecified adverse effect of drug or medicament Non-standardCIM10 Y43 Adverse effects in the therapeutic use of primarily systemic agents Non-standardCIM10 Y43.0 Adverse effects in the therapeutic use of antiallergic and antiemetic drugs Non-standardCIM10 Y43.5 Adverse effects in the therapeutic use of acidifying and alkalizing agents Non-standardCIM10 Y43.8 Adverse effects in the therapeutic use of other primarily systemic agents, not elsewhere classified Non-standardCIM10 Y43.9 Adverse effects in the therapeutic use of primarily systemic agent, unspecified Non-standardCIM10 Y45 Adverse effects in the therapeutic use of analgesics, antipyretics and anti-inflammatory drugs Non-standardCIM10 Y45.8 Adverse effects in the therapeutic use of other analgesics and antipyretics Non-standardCIM10 Y45.9 Adverse effects in the therapeutic use of analgesic, antipyretic and anti-inflammatory drug, unspecified Non-standardCIM10 Y47.5 Adverse effects in the therapeutic use of mixed sedatives and hypnotics, not elsewhere classified Non-standardCIM10 Y47.8 Adverse effects in the therapeutic use of other sedatives, hypnotics and antianxiety drugs Non-standardCIM10 Y47.9 Adverse effects in the therapeutic use of sedative, hypnotic and antianxiety drug, unspecified Non-standardCIM10 Y49 Adverse effects in the therapeutic use of psychotropic drugs, not elsewhere classified Non-standardCIM10 Y49.5 Adverse effects in the therapeutic use of other antipsychotics and neuroleptics Non-standardCIM10 Y49.7 Adverse effects in the therapeutic use of psychostimulants with abuse potential Non-standardCIM10 Y49.8 Adverse effects in the therapeutic use of other psychotropic drugs, not elsewhere classified Non-standardCIM10 Y49.9 Adverse effects in the therapeutic use of psychotropic drug, unspecified Non-standardCIM10 Y51 Adverse effects in the therapeutic use of drugs primarily affecting the autonomic nervous system Non-standardCIM10 Y51.3 Adverse effects in the therapeutic use of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified Non-standardCIM10 Y54 Adverse effects in the therapeutic use of agents primarily affecting water-balance and mineral and uric acid metabolism Non-standardCIM10 Y54.6 Adverse effects in the therapeutic use of electrolytic, caloric and water-balance agents Non-standardCIM10 Y54.8 Adverse effects in the therapeutic use of agents affecting uric acid metabolism Non-standardCIM10 Y55.5 Adverse effects in the therapeutic use of anti-common-cold drugs Non-standardCIM10 Y56.2 Adverse effects in the therapeutic use of local astringents and local detergents Non-standardCIM10 Y56.4 Adverse effects in the therapeutic use of keratolytics, keratoplastics and other hair treatment drugs and preparations Non-standardCIM10 Y56.5 Adverse effects in the therapeutic use of ophthalmological drugs and preparations Non-standardCIM10 Y56.6 Adverse effects in the therapeutic use of otorhinolaryngological drugs and preparations Non-standardCIM10 Y56.7 Adverse effects in the therapeutic use of dental drugs, topically applied Non-standardCIM10 Y57 Adverse effects in the therapeutic use of other and unspecified drugs and medicaments Non-standardCIM10 Y57.3 Adverse effects in the therapeutic use of alcohol deterrents Non-standardCIM10 Y57.8 Adverse effects in the therapeutic use of other drugs and medicaments Non-standardCIM10 Y57.9 Adverse effects in the therapeutic use of drug or medicament, unspecified Non-standardCO-CONNECT TWINS Q18_23 Bad reaction to medication Non-standardHPO HP_0020172 Adverse drug response Non-standardICD10 T88.7 Unspecified adverse effect of drug or medicament Non-standardICD10 Y43 Adverse effects in the therapeutic use of primarily systemic agents Non-standardICD10 Y43.0 Adverse effects in the therapeutic use of antiallergic and antiemetic drugs Non-standardICD10 Y43.5 Adverse effects in the therapeutic use of acidifying and alkalizing agents Non-standardICD10 Y43.8 Adverse effects in the therapeutic use of other primarily systemic agents, not elsewhere classified Non-standardICD10 Y43.9 Adverse effects in the therapeutic use of primarily systemic agent, unspecified Non-standardICD10 Y45 Adverse effects in the therapeutic use of analgesics, antipyretics and anti-inflammatory drugs Non-standardICD10 Y45.8 Adverse effects in the therapeutic use of other analgesics and antipyretics Non-standardICD10 Y45.9 Adverse effects in the therapeutic use of analgesic, antipyretic and anti-inflammatory drug, unspecified Non-standardICD10 Y47.5 Adverse effects in the therapeutic use of mixed sedatives and hypnotics, not elsewhere classified Non-standardICD10 Y47.8 Adverse effects in the therapeutic use of other sedatives, hypnotics and antianxiety drugs Non-standardICD10 Y47.9 Adverse effects in the therapeutic use of sedative, hypnotic and antianxiety drug, unspecified Non-standardICD10 Y49 Adverse effects in the therapeutic use of psychotropic drugs, not elsewhere classified Non-standardICD10 Y49.5 Adverse effects in the therapeutic use of other antipsychotics and neuroleptics Non-standardICD10 Y49.7 Adverse effects in the therapeutic use of psychostimulants with abuse potential Non-standardICD10 Y49.8 Adverse effects in the therapeutic use of other psychotropic drugs, not elsewhere classified Non-standardICD10 Y49.9 Adverse effects in the therapeutic use of psychotropic drug, unspecified Non-standardICD10 Y51 Adverse effects in the therapeutic use of drugs primarily affecting the autonomic nervous system Non-standardICD10 Y51.3 Adverse effects in the therapeutic use of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified Non-standardICD10 Y54 Adverse effects in the therapeutic use of agents primarily affecting water-balance and mineral and uric acid metabolism Non-standardICD10 Y54.6 Adverse effects in the therapeutic use of electrolytic, caloric and water-balance agents Non-standardICD10 Y54.8 Adverse effects in the therapeutic use of agents affecting uric acid metabolism Non-standardICD10 Y55.5 Adverse effects in the therapeutic use of anti-common-cold drugs Non-standardICD10 Y56.2 Adverse effects in the therapeutic use of local astringents and local detergents Non-standardICD10 Y56.4 Adverse effects in the therapeutic use of keratolytics, keratoplastics and other hair treatment drugs and preparations Non-standardICD10 Y56.5 Adverse effects in the therapeutic use of ophthalmological drugs and preparations Non-standardICD10 Y56.6 Adverse effects in the therapeutic use of otorhinolaryngological drugs and preparations Non-standardICD10 Y56.7 Adverse effects in the therapeutic use of dental drugs, topically applied Non-standardICD10 Y57 Adverse effects in the therapeutic use of other and unspecified drugs and medicaments Non-standardICD10 Y57.3 Adverse effects in the therapeutic use of alcohol deterrents Non-standardICD10 Y57.8 Adverse effects in the therapeutic use of other drugs and medicaments Non-standardICD10 Y57.9 Adverse effects in the therapeutic use of drug or medicament, unspecified Non-standardICD10CM T38.0X5 Adverse effect of glucocorticoids and synthetic analogues Non-standardICD10CM T38.0X5A Adverse effect of glucocorticoids and synthetic analogues, initial encounter Non-standardICD10CM T38.0X5D Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter Non-standardICD10CM T39.95 Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic Non-standardICD10CM T40.495 Adverse effect of other synthetic narcotics Non-standardICD10CM T40.495A Adverse effect of other synthetic narcotics, initial encounter Non-standardICD10CM T40.495D Adverse effect of other synthetic narcotics, subsequent encounter Non-standardICD10CM T40.495S Adverse effect of other synthetic narcotics, sequela Non-standardICD10CM T40.605 Adverse effect of unspecified narcotics Non-standardICD10CM T40.605A Adverse effect of unspecified narcotics, initial encounter Non-standardICD10CM T40.605D Adverse effect of unspecified narcotics, subsequent encounter Non-standardICD10CM T40.695 Adverse effect of other narcotics Non-standard